In multiple patient-derived xenograft models of small cell lung cancer, combination therapy with the mTOR inhibitor Everolimus and the BRD4 inhibitor NHWD870 synergistically induce cancer cell apoptosis and blocks tumor progression without significantly increasing toxicity to normal tissues in mice [52]. The gene discussed is MTOR; the disease is cancer.